Latest Financial Reporting News

Critical Resources Limited (ASX:CRR) has initiated a pro-rata entitlement offer of Loyalty Options priced at $0.001 each, aiming to raise $319,410 and potentially $2.56 million upon exercise. The offer underscores significant dilution and operational risks amid ongoing exploration and legal challenges.

NeuRizer Ltd advanced its urea project with Reliance Industries payments and environmental submissions, despite ongoing ASX trading suspension and overdue financial reports.

Merino & Co. reported Q3 FY26 revenue of A$441,558 with new domestic and China purchase orders supporting its growth strategy, while cash reserves fell to A$654,282 due to investments in production and marketing.

The Hydration Pharmaceuticals Company Limited (ASX: HPC) temporarily halted trading to relodge its FY25 Annual Report, revealing a $2.86 million loss driven by US market rationalisation and ongoing cost-cutting.

DUG Technology Ltd recorded a 35% revenue increase in FY26-Q3, surpassing full-year FY25 revenue in just nine months and announcing a strategic move to half-year financial reporting.

Omni Bridgeway reports strong investment activity and a robust pipeline for Q3 2026, maintaining solid returns and cost discipline amid global market volatility.

Genesis Resources progresses environmental work at its Plavica project in North Macedonia while Australian field activities stall due to wet season, reporting a A$401k operating cash outflow and under two quarters of funding.

Brockman Mining Limited continues to develop its Marillana and Ophthalmia iron ore projects through joint ventures, progressing infrastructure plans at Port Hedland while maintaining a modest cash position and strong financing facilities.

Middle Island Resources has completed its Phase 2 drilling at the Bobija polymetallic project in Serbia, reinforcing continuity of gold-silver-base metal mineralisation. Extensive soil sampling across Tisovik, Priboj, and Ober projects has identified multiple promising targets, with RC drilling planned pending land access approvals.

Biome Australia’s Activated Probiotics brand surpasses one million boxes sold in Australia, approaches top pharmacy ranking, and launches nationally in Canada, setting the stage for FY26 profitability.

Kuniko Limited has launched a prospectus offering over 51 million new options following a $3.75 million share placement, aiming to facilitate secondary trading and potential future capital raising through option exercises.

Invex Therapeutics reported promising preclinical findings on Exenatide’s effects in a human Alzheimer's disease model, alongside a steady cash position and reduced operating outflows in Q3 FY26.